<DOC>
	<DOC>NCT00881270</DOC>
	<brief_summary>Primary Objective: To prove the safety of the formulation in normal conditions of use.</brief_summary>
	<brief_title>Dermacyd Infantile - Acceptability.</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Integral skin test in the region Use the same category of cosmetics Willingness in following the study procedures and to be present in the clinic at the days and scheduled time. Exclusion criteria: Use of Antiinflammatory, immunosuppressant or antihistaminic drugs Allergic or atopic history to cosmetics products Cutaneous active disease (local or general) in the evaluated area Disease which can cause immunosuppressant, such as diabetes, HIV Endocrine pathology Intensive solar exposure until 15 days before evaluation Treatment four months before selection. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>